Records containing: Retinal Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-07-02Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases
-
CLINICAL_TRIALS study record update · 2017-03-14Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
-
CLINICAL_TRIALS study record update · 2016-01-22Erythrocyte Ghost Mediated Retinal Diagnosis
-
CLINICAL_TRIALS study record update · 2015-06-17Topcon 3D OCT-1000 Optical Coherence Tomography System for Measurements of Retinal and RNFL Thicknesses: Precision and Agreement Study
-
CLINICAL_TRIALS study record update · 2014-12-04Phase II, Randomized, Placebo-Controlled Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-11-19Pilot Phase I/II Study of the Treatment of Classic Central Serous Chorioretinopathy With Topical Interferon Gamma-1b
-
CLINICAL_TRIALS study record update · 2014-09-29Crossed Precision Design Study of the Nidek Optical Coherence Tomography RS-3000, RS-3000 Lite and RS-3000 Advance for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, and Pachymetry
-
CLINICAL_TRIALS study record update · 2013-09-23Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
-
CLINICAL_TRIALS study record update · 2013-07-15A Phase 3, Randomized, Controlled, Double-Masked, Multi-Center, Comparative, In Parallel Groups (For 24 Weeks), To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium, With Sham Injections, And Open Study (For 30 Weeks) To Confirm The Safety Of 0.3 MG Pegaptanib Sodium In Subjects With Diabetic Macular Edema (DME)
-
CLINICAL_TRIALS study record update · 2013-04-08Immune Ablation and Hematopoietic Stem Cell Transplantation in Patients With Autoimmune-Related Retinopathy and Optic Neuropathy (ARRON) Syndrome (Not Associated With Cancer)
-
CLINICAL_TRIALS study record update · 2012-02-20Comparative Study of the Nidek Optical Coherence Tomography RS-3000 and the RTVue OCT Predicate Device for the Measurements of Retinal and RNFL Thickness, Optic Disc Analysis, Pachymetry, Anterior Chamber Imaging and SLO Imaging.
-
CLINICAL_TRIALS study record update · 2011-05-30Research Study in Patients With Persistent Macular Edema Due to Diabetic Retinopathy, Retinal Vein Occlusion, Uveitis, or Irvine-Gass Syndrome
-
CLINICAL_TRIALS study record update · 2011-05-16Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
-
CLINICAL_TRIALS study record update · 2009-12-23CPAP Application at Delivery Room at Very Low Birth Weight Infants
-
CLINICAL_TRIALS study record update · 2009-11-25Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2008-03-04A Study to Investigate the Safety and Efficacy of HAT to Treat the Ocular Complications Related to Behcet's Disease
-
CLINICAL_TRIALS study record update · 2008-03-04Optical Coherence Tomography Comparative Study